> 연구 활동 >
| KASTT No. | 논문제목 | 주저자 | 저널 |
|---|---|---|---|
| KASTT001 | Clinical Activity of Pan-HER Inhibitors Against HER2-Mutant Lung Adenocarcinoma | 오인재/최창민 | Clinical Lung Cancer |
| KASTT002 | Extracellular vesicle-derived DNA for performing EGFR genotyping of NSCLC patients | 허재영/이계영 | Molecular Cancer |
| KASTT004 | Phase II open-label multicenter study to assess the antitumor activity of afatinib in lung cancer patients with activating epidermal growth factor receptor mutation from circulating tumor DNA: Liquid-Lung-A | 박철규/김영철 | Thoracic Cancer |
| KASTT-20190111 | Histone Deacetylase as a Valuable Predictive Biomarker and Therapeutic Target in Immunotherapy for Non–Small Cell Lung Cancer | 신현석/이승룡 | Cancer Research and Treatment |
| KASTT-20190121 | Multicenter real-world data of patients harboring rare mutations other than EGFR or ALK in advanced or metastatic non-small cell lung cancer | 이수연/최창민 | Thoracic Cancer |
| KASTT-20190211 | Circulating regulatory T cells predict efficacy and atypical responses in lung cancer patients treated with PD-1/PD-L1 inhibitors | 강다현/이정은 | Cancer Immunology Immunotherapy |
| KASTT-20200111 | Afatinib Mediates Autophagic Degradation of ORAI1, STIM1, and SERCA2, Which Inhibits Proliferation of Non-Small Cell Lung Cancer Cells | 김미성/양세훈, 김민석 |
Tuberculosis and Respiratory Disease |
| KASTT-20210211 | Generation of genetically engineered mice for lung cancer with mutant EGFR | 김다솜, 지원준/성영훈, 노진경 |
Biochemical and Biophysical Research Communications |